Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression - PubMed (original) (raw)

Review

doi: 10.1038/ncpcardio1110. Epub 2008 Jan 29.

Affiliations

• PMID: 18227814
• DOI: 10.1038/ncpcardio1110

Review

Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression

Andre Keren et al. Nat Clin Pract Cardiovasc Med. 2008 Mar.

Erratum in

• Nat Clin Pract Cardiovasc Med. 2008 Nov;5(11):747

Abstract

Hypertrophic cardiomyopathy (HCM), defined clinically by the presence of unexplained left ventricular hypertrophy, is the most common inherited cardiac disorder. This condition is the major cause of sudden death in the young (<30 years of age) and in athletes. The clinical phenotype is heterogeneous, and mutations in a number of sarcomeric contractile-protein genes are responsible for causing the disease in approximately 60% of individuals with HCM. Other inherited syndromes, as well as metabolic and mitochondrial disorders, can present as clinical phenocopies and can be distinguished by their associated cardiac and noncardiac features and on the basis of their unique molecular genetics. The mode of inheritance, natural history and treatment of phenocopies can differ from those of HCM caused by mutations in sarcomere genes. Detailed clinical evaluation and mutation analysis are, therefore, important in providing an accurate diagnosis in order to enable genetic counseling, prognostic evaluation and appropriate clinical management. This Review summarizes current knowledge on the genetics, disease mechanisms, and correlations between phenotype and genotype in patients with HCM, and discusses the implications of genetic testing in routine clinical practice.

PubMed Disclaimer

Similar articles

• Familial hypertrophic cardiomyopathy: clinical features, molecular genetics and molecular genetic testing.
  Taylor MR, Carniel E, Mestroni L. Taylor MR, et al. Expert Rev Mol Diagn. 2004 Jan;4(1):99-113. doi: 10.1586/14737159.4.1.99. Expert Rev Mol Diagn. 2004. PMID: 14711353 Review.
• Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype.
  Kubo T, Gimeno JR, Bahl A, Steffensen U, Steffensen M, Osman E, Thaman R, Mogensen J, Elliott PM, Doi Y, McKenna WJ. Kubo T, et al. J Am Coll Cardiol. 2007 Jun 26;49(25):2419-26. doi: 10.1016/j.jacc.2007.02.061. Epub 2007 Jun 11. J Am Coll Cardiol. 2007. PMID: 17599605
• [Evaluation of the risk of sudden death in hypertrophic cardiomyopathy].
  Sadoul N, de Chillou C, Aliot E, McKenna WJ. Sadoul N, et al. Arch Mal Coeur Vaiss. 1999 Apr;92 Spec No 1:65-73. Arch Mal Coeur Vaiss. 1999. PMID: 10326160 Review. French.
• Molecular genetics of familial hypertrophic cardiomyopathy (FHC).
  Bashyam MD, Savithri GR, Kumar MS, Narasimhan C, Nallari P. Bashyam MD, et al. J Hum Genet. 2003;48(2):55-64. doi: 10.1007/s100380300007. J Hum Genet. 2003. PMID: 12601548 Review.
• Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations.
  Olivotto I, Girolami F, Sciagrà R, Ackerman MJ, Sotgia B, Bos JM, Nistri S, Sgalambro A, Grifoni C, Torricelli F, Camici PG, Cecchi F. Olivotto I, et al. J Am Coll Cardiol. 2011 Aug 16;58(8):839-48. doi: 10.1016/j.jacc.2011.05.018. J Am Coll Cardiol. 2011. PMID: 21835320

Cited by

• Myosin inhibitor reverses hypertrophic cardiomyopathy in genotypically diverse pediatric iPSC-cardiomyocytes to mirror variant correction.
  Kinnear C, Said A, Meng G, Zhao Y, Wang EY, Rafatian N, Parmar N, Wei W, Billia F, Simmons CA, Radisic M, Ellis J, Mital S. Kinnear C, et al. Cell Rep Med. 2024 May 21;5(5):101520. doi: 10.1016/j.xcrm.2024.101520. Epub 2024 Apr 19. Cell Rep Med. 2024. PMID: 38642550 Free PMC article.
• Presence of known feline ALMS1 and MYBPC3 variants in a diverse cohort of cats with hypertrophic cardiomyopathy in Japan.
  Akiyama N, Suzuki R, Saito T, Yuchi Y, Ukawa H, Matsumoto Y. Akiyama N, et al. PLoS One. 2023 Apr 18;18(4):e0283433. doi: 10.1371/journal.pone.0283433. eCollection 2023. PLoS One. 2023. PMID: 37071642 Free PMC article.
• Severe hypertrophic cardiomyopathy in a patient with a homozygous MYH7 gene variant.
  Serra W, Vitetta G, Uliana V, Barocelli F, Barili V, Allegri I, Ardissino D, Gualandi F, Percesepe A. Serra W, et al. Heliyon. 2022 Dec 16;8(12):e12373. doi: 10.1016/j.heliyon.2022.e12373. eCollection 2022 Dec. Heliyon. 2022. PMID: 36593836 Free PMC article.
• Left atrial dysfunction may precede left atrial enlargement and abnormal left ventricular longitudinal function: a cardiac MR feature tracking study.
  Zhou D, Yang W, Yang Y, Yin G, Li S, Zhuang B, Xu J, He J, Wu W, Jiang Y, Sun X, Wang Y, Sirajuddin A, Zhao S, Lu M. Zhou D, et al. BMC Cardiovasc Disord. 2022 Mar 13;22(1):99. doi: 10.1186/s12872-022-02532-w. BMC Cardiovasc Disord. 2022. PMID: 35282817 Free PMC article.
• Polar Gini Curve: A Technique to Discover Gene Expression Spatial Patterns from Single-cell RNA-seq Data.
  Nguyen TM, Jeevan JJ, Xu N, Chen JY. Nguyen TM, et al. Genomics Proteomics Bioinformatics. 2021 Jun;19(3):493-503. doi: 10.1016/j.gpb.2020.09.006. Epub 2021 Dec 25. Genomics Proteomics Bioinformatics. 2021. PMID: 34958962 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.

• Medical

  • MedlinePlus Health Information